Sökning: WFRF:(Cervello Irene) > Tissue-derived mese...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04387naa a2200469 4500 | |
001 | oai:DiVA.org:uu-203289 | |
003 | SwePub | |
008 | 130708s2013 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2032892 URI |
024 | 7 | a https://doi.org/10.1186/1741-7015-11-1392 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Belmar-Lopez, Carolina4 aut |
245 | 1 0 | a Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth |
264 | c 2013-05-28 | |
264 | 1 | b Springer Science and Business Media LLC,c 2013 |
338 | a electronic2 rdacarrier | |
520 | a Background: Mesenchymal stem cells (MSCs) have been promoted as an attractive option to use as cellular delivery vehicles to carry anti-tumor agents, owing to their ability to home into tumor sites and secrete cytokines. Multiple isolated populations have been described as MSCs, but despite extensive in vitro characterization, little is known about their in vivo behavior. The aim of this study was to investigate the efficacy and efficiency of different MSC lineages derived from five different sources (bone marrow, adipose tissue, epithelial endometrium, stroma endometrium, and amniotic membrane), in order to assess their adequacy for cell-based anti-tumor therapies. Our study shows the crucial importance of understanding the interaction between MSCs and tumor cells, and provides both information and a methodological approach, which could be used to develop safer and more accurate targeted therapeutic applications. Methods: We first measured the in vivo migration capacity and effect on tumor growth of the different MSCs using two imaging techniques: (i) single-photon emission computed tomography combined with computed tomography (SPECT-CT), using the human sodium iodine symporter gene (hNIS) and (ii) magnetic resonance imaging using superparamagnetic iron oxide. We then sought correlations between these parameters and expression of pluripotency-related or migration-related genes. Results: Our results show that migration of human bone marrow-derived MSCs was significantly reduced and slower than that obtained with the other MSCs assayed and also with human induced pluripotent stem cells (hiPSCs). The qPCR data clearly show that MSCs and hiPSCs exert a very different pluripotency pattern, which correlates with the differences observed in their engraftment capacity and with their effects on tumor growth. Conclusion: This study reveals differences in MSC recruitment/migration toward the tumor site and the corresponding effects on tumor growth. Three observations stand out: 1) tracking of the stem cell is essential to check the safety and efficacy of cell therapies; 2) the MSC lineage to be used in the cell therapy needs to be carefully chosen to balance efficacy and safety for a particular tumor type; and 3) different pluripotency and mobility patterns can be linked to the engraftment capacity of the MSCs, and should be checked as part of the clinical characterization of the lineage. | |
653 | a Mesenchymal stromal cells | |
653 | a Migration | |
653 | a In vivo imaging | |
653 | a Tumor growth | |
653 | a Pluripotency | |
700 | 1 | a Mendoza, Gracia4 aut |
700 | 1 | a Öberg, Danielu Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi4 aut0 (Swepub:uu)daobe475 |
700 | 1 | a Burnet, Jerome4 aut |
700 | 1 | a Simon, Carlos4 aut |
700 | 1 | a Cervello, Irene4 aut |
700 | 1 | a Iglesias, Maite4 aut |
700 | 1 | a Carlos Ramirez, Juan4 aut |
700 | 1 | a Lopez-Larrubia, Pilar4 aut |
700 | 1 | a Quintanilla, Miguel4 aut |
700 | 1 | a Martin-Duque, Pilar4 aut |
710 | 2 | a Uppsala universitetb Institutionen för medicinsk biokemi och mikrobiologi4 org |
773 | 0 | t BMC Medicined : Springer Science and Business Media LLCg 11, s. 139-q 11<139-x 1741-7015 |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:636192/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://bmcmedicine.biomedcentral.com/track/pdf/10.1186/1741-7015-11-139 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-203289 |
856 | 4 8 | u https://doi.org/10.1186/1741-7015-11-139 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.